Related Experiment Videos
Complement receptor 1 gene polymorphisms in sarcoidosis
Michele Zorzetto1, Cristina Bombieri, Ilaria Ferrarotti
1Laboratorio di Biochimica e Genetica, Clinica di Malattie dell'Apparato Respiratorio, Pavia, Italy.
Insights
Genetic factors may influence sarcoidosis risk. A specific CR1 gene variant (Pro1827Arg GG genotype) was linked to increased sarcoidosis occurrence, particularly in females, suggesting a role in disease susceptibility.
Area of Science:
- Immunogenetics
- Environmental Medicine
- Rheumatology
Background:
- Sarcoidosis is an inflammatory disease potentially triggered by environmental factors in genetically susceptible individuals.
- Erythrocyte complement receptor 1 (CR1) plays a role in immune complex clearance, with CR1 gene polymorphisms affecting its surface density.
- Reduced CR1 density may impair immune complex handling, potentially contributing to sarcoidosis pathogenesis.
Purpose of the Study:
- To investigate the association between CR1 gene polymorphisms and sarcoidosis.
- To determine if specific CR1 alleles correlate with sarcoidosis susceptibility.
- To explore potential sex-specific genetic associations with sarcoidosis.
Main Methods:
- Genotyping of three CR1 gene polymorphic sites (His1208Arg, intron 27 HindIII/RFLP, Pro1827Arg) in 91 sarcoidosis patients and 165 controls (healthy volunteers and COPD patients).
- Analysis of linkage disequilibrium among the studied polymorphisms.
- Statistical analysis to compare allele and genotype frequencies between sarcoidosis patients and control groups, including subgroup analysis for females.
Main Results:
- The GG genotype for the Pro1827Arg (C5507G) polymorphism showed a significant association with sarcoidosis compared to both healthy and COPD control groups (ORs ranging from 2.82 to 3.13).
- This specific genotype was found to be particularly associated with sarcoidosis in female patients (OR = 7.05 compared to healthy controls).
- The three studied CR1 polymorphisms were in linkage disequilibrium.
Conclusions:
- The CR1 gene, specifically the Pro1827Arg polymorphism (GG genotype), may represent a susceptibility factor for sarcoidosis.
- The findings support the hypothesis that CR1 gene variations influence sarcoidosis risk, potentially through altered immune complex clearance.
- The strong association in females warrants further investigation into sex-specific genetic contributions to sarcoidosis.
Abstract:
Sarcoidosis is likely to result from exposure of genetically susceptible hosts to environmental agents. Erythrocyte (E) complement receptor 1 (CR1) is a membrane protein mediating the transport of immune complexes (ICs) to phagocytes, and at least three polymorphisms on the CR1 gene are related to erythrocyte surface density of CR1 molecules, in turn related to the rate of IC clearance from circulation. We hypothesized that sarcoidosis could be associated with increased frequency of the CR1 gene alleles coding for reduced CR1/E ratio. We studied 91 sarcoid patients and two control groups: 94 healthy volunteers and 71 patients with chronic obstructive pulmonary disease (COPD). Three polymorphic sites of CR1 gene, His1208Arg, intron 27 HindIII/RFLP, and Pro1827Arg, were analyzed. The three polymorphisms were in linkage disequilibrium. The GG genotype for the Pro1827Arg (C(5507)G) polymorphism was significantly associated with sarcoidosis in comparison to both control groups (odds ratio [OR] = 3.13; 95% confidence interval [CI] 1.49-6.69 versus healthy control subjects, and OR= 2.82, 95% CI 1.27-6.39 versus COPD control subjects). The same genotype was particularly associated to disease in females (OR = 7.05; 95% CI 3.10-16.61 versus healthy control subjects). These findings agree with speculations on the role of CR1 gene as a possible susceptibility factor.